25 May 2013
Keywords: biovail, gsk, sign, million, marketing, deal, bupropion
Article | 29 October 2001
GlaxoSmithKline and Canada's Biovail Corp have signed a deal wherebythe latter has licensed to the UK firm a novel controlled-release,
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 October 2001
30 October 2001
24 May 2013
© 2013 thepharmaletter.com